Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: FDA

Beyond The Roundup | Fact Checking The Fact Checkers: Associated Press VS Ivermectin

Fact Checking the Fact Checkers: The Case of Ivermectin for Publicly-Subsidized Research:On December 11, TrialSite News reported on a US […]

Fact Checking The Fact Checkers: Associated Press VS Ivermectin
3 months ago
Share

COVID-19 Early Treatment Fund & WUSM St. Louis Pursue Fluvoxamine as Early Stage Treatment for COVID-19: Positive Momentum

Washington University School of Medicine in St. Louis (WUSM St. Louis) investigators are now preparing for a critically important Phase 3 clinical […]

COVID-19 Early Treatment Fund & WUSM St. Louis Pursue Fluvoxamine as Early Stage Treatment for COVID-19 Positive Momentum
3 months ago
Share

Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the United States

 Moderna, Inc., (Nasdaq:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative […]

Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the United States
3 months ago
Share

U of M Medical School Research Led to FDA Approval of New Anti-obesity Medication for Adolescents

One in five teenagers in the U.S. is afflicted with obesity and the prevalence continues to rise. That statistic could […]

U of M Medical School Research Led to FDA Approval of New Anti-obesity Medication for Adolescents
3 months ago
Share

FDA Committee Votes to Recommend Emergency Use Authorization of Pfizer/BioNTech Coronavirus Vaccine

Reported by Maggie Fox with CNN, the US Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted […]

FDA Committee Votes to Recommend Emergency Use Authorization of PfizerBioNTech Coronavirus Vaccine
3 months ago
Share

Moderna files for Emergency Use Authorization with FDA for mRNA-1273

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative […]

Moderna files for Emergency Use Authorization with FDA for mRNA-1273
3 months ago
Share

U.S. FDA Authorizes Regeneron’s REGN-COV2 Monoclonal Antibody for Emergency Use Authorization Targeting Select COVID-19 Patients

The monoclonal antibody cocktail developed by Regeneron and made well-known by POTUS during his stay at Walter Reed Medical Center […]

U.S. FDA Authorizes Regeneron’s REGN-COV2 Monoclonal Antibody for Emergency Use Authorization Targeting Select COVID-19 Patients
3 months ago
Share

PFIZER AND BIONTECH TO SUBMIT EMERGENCY USE AUTHORIZATION REQUEST TODAY TO THE U.S. FDA FOR COVID-19 VACCINE

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration […]

PFIZER AND BIONTECH TO SUBMIT EMERGENCY USE AUTHORIZATION REQUEST TODAY TO THE U.S. FDA FOR COVID-19 VACCINE
4 months ago
Share

Lilly’s Bamlanivimab (LY-CoV555) Receives FDA Emergency Use Authorization: A First COVID-19 Patients at High Risk

The U.S. Food and Drug Administration (FDA) today granted the first Emergency Use Authorization (EUA) for a monoclonal antibody targeting SARS-CoV-2, the […]

Lilly’s Bamlanivimab (LY-CoV555) Receives FDA Emergency Use Authorization A First COVID-19 Patients at High Risk
4 months ago
Share

U.S. FDA Shares Final Guidance to Enhance Diversity of Clinical Trials

The COVID-19 pandemic has reminded all that track health, research and the impact of disease on minority and underserved or […]

U.S. FDA Shares Final Guidance to Enhance Diversity of Clinical Trials
4 months ago
Share

Posts navigation

Older posts
Newer posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.